CIPROFLOXACIN HCL
TYPHOID FEVER·+68
WEST-WARD,INC.
Indication
Pseudomonas aeruginosa pneumonia
*Pseudomonas aeruginosa* pneumonia is an acute or chronic lower respiratory tract infection caused by the opportunistic Gram-negative bacterium *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa pneumonia
168 drugs 86 manufacturers
Drugs that treat it
Common Pseudomonas aeruginosa pneumonia therapies.
CIPROFLOXACIN HCL
QUINOLONES·TYPHOID FEVER·+68
CARLSBAD TECH
CIPROFLOXACIN HCL
QUINOLONES·TYPHOID FEVER·+68
MYLAN INSTITUTI
TOBRAMYCIN SULFATE
E. COLI SEPTICEMIA·+44
APP PHARMACEUTI
CEFTAZIDIME
MENINGOCOCCAL MENINGITIS·+67
SANDOZ
CEFTAZIDIME
BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+67
SAGENT PHARMACE
TAZICEF (ceftazidime)
MENINGOCOCCAL MENINGITIS·+67
HOSPIRA
AMIKACIN SULFATE
STAPHYLOCOCCAL SEPTICEMIA·+60
Teva Parenteral Medicines
CEFEPIME HCL
BETA-LACTAMS·FEBRILE NEUTROPENIC PATIENT PRESUMED INFECTION TREATMENT·+26
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa pneumonia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Pseudomonas aeruginosa* pneumonia is an acute or chronic lower respiratory tract infection caused by the opportunistic Gram-negative bacterium *Pseudomonas aeruginosa*.
It most commonly affects hospitalized individuals, particularly critically ill patients receiving mechanical ventilation, as well as immunocompromised hosts and individuals with pre-existing structural lung diseases such as cystic fibrosis or bronchiectasis.
Pathophysiologically, the organism employs an array of virulence mechanisms—including elastases, exotoxins, and biofilm formation—to cause extensive epithelial injury, parenchymal necrosis, and marked alveolar inflammation.
Defining clinical features include fever, dyspnea, hypoxemia, and purulent sputum production, frequently complicated by extensive pulmonary infiltrates, tissue cavitations, and a high risk of respiratory failure.
- nih.gov
*Pseudomonas aeruginosa* pneumonia is an acute or chronic lower respiratory tract infection caused by the opportunistic Gram-negative bacterium *Pseudomonas aeruginosa* It most commonly affects hospitalized individuals, particularly critically ill patients receiving mechanical ventilation, as well as immunocompromised hosts and individuals with pre-existing structural lung diseases such as cystic fibrosis or bronchiectasis Pathophysiologically, the organism employs an array of virulence mechanis...
- nih.gov
*Pseudomonas aeruginosa* pneumonia is an acute or chronic lower respiratory tract infection caused by the opportunistic Gram-negative bacterium *Pseudomonas aeruginosa*
- cdc.gov
It most commonly affects hospitalized individuals, particularly critically ill patients receiving mechanical ventilation, as well as immunocompromised hosts and individuals with pre-existing structural lung diseases such as cystic fibrosis or bronchiectasis
- bronchandntm.org
It most commonly affects hospitalized individuals, particularly critically ill patients receiving mechanical ventilation, as well as immunocompromised hosts and individuals with pre-existing structural lung diseases such as cystic fibrosis or bronchiectasis Defining clinical features include fever, dyspnea, hypoxemia, and purulent sputum production, frequently complicated by extensive pulmonary infiltrates, tissue cavitations, and a high risk of respiratory failure
- nih.gov
Pathophysiologically, the organism employs an array of virulence mechanisms—including elastases, exotoxins, and biofilm formation—to cause extensive epithelial injury, parenchymal necrosis, and marked alveolar inflammation
- nih.gov
Defining clinical features include fever, dyspnea, hypoxemia, and purulent sputum production, frequently complicated by extensive pulmonary infiltrates, tissue cavitations, and a high risk of respiratory failure
- nih.gov
Defining clinical features include fever, dyspnea, hypoxemia, and purulent sputum production, frequently complicated by extensive pulmonary infiltrates, tissue cavitations, and a high risk of respiratory failure
Personalize your experience
Follow Pseudomonas aeruginosa pneumonia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.